'Nuchal translucency' presentation slideshows

Prenatal screening & Diagnosis

Prenatal screening & Diagnosis. Prenatal screening & Diagnosis. Supachai Nathongchai, MD. Department of Obstetrics and Gynecology SomdejprachoaTaksinmaharaj Hospital. Concept of Screening. Population (pregnant women). Screening test. Screen Positive. Screen Negative.

2.5k views • 91 slides

Evidence Based Diagnosis Mark J. Pletcher, MD MPH 6/28/2012

808 views • 66 slides

Routine Anomaly Scan

1.24k views • 55 slides

Photo: courtesy Travel Alberta

Early Risk Assessment Program: Performance Update 2008. Photo: courtesy Travel Alberta. Screening for Fetal Aneuploidy 11-13+6 weeks. Objectives:. The provision of information for individuals. 32 nd RCOG Study Group.

633 views • 49 slides

IN THE NAME OF GOD

IN THE NAME OF GOD. Prenatal screening. E . ZAREAN Fellowship of perinatology. Congenital Disorder. Genetic Chromosomal Enviromental Infection Morphogenesis defect. Baseline Risk for Having a Child With a Serious Birth Defect. 3-5%. First and Second Trimester Screening.

402 views • 40 slides

DR.ALAA Ibrahim

378 views • 36 slides

First and Second Trimester Trisomy Screening

First and Second Trimester Trisomy Screening. J. Christopher Glantz. Trisomies 21, 18, and 13. Incidence (live births) 21: 1/6-800 18: 1/7,000 13: <1/10,000 Trimester Frequency: First>Second>Third Spontaneous and induced losses 20-30% for 21, 40% for 13, 66% for 18

663 views • 31 slides

Pregnancy & Newborn Screening Developments

393 views • 18 slides